Cargando…

Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination

Detalles Bibliográficos
Autores principales:	Ehmsen, Sidse, Asmussen, Anders, Jeppesen, Stefan S., Nilsson, Anna Christine, Østerlev, Sabina, Kragh, Amalie, Frederiksen, Henrik, Ditzel, Henrik J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867110/ https://www.ncbi.nlm.nih.gov/pubmed/35216675 http://dx.doi.org/10.1016/j.ccell.2022.02.011

Ejemplares similares

Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
por: Ehmsen, Sidse, et al.
Publicado: (2022)

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
por: Ehmsen, Sidse, et al.
Publicado: (2021)

BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer
por: Ehmsen, Sidse, et al.
Publicado: (2023)

Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
por: Skov, Natascha, et al.
Publicado: (2022)

Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency
por: Nielsen, Bibi Uhre, et al.
Publicado: (2022)

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
por: Sanada, Takahiro, et al.
Publicado: (2023)

Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer
por: Kodahl, Annette R., et al.
Publicado: (2018)

(347) Augmented Humoral Response to a Third And Fourth Dose of Mrna Sars-Cov-2 Vaccines in Lung Transplant Recipients
por: Kawana, S., et al.
Publicado: (2023)

Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor
por: Karimi, Leena, et al.
Publicado: (2023)

Antibody Titers After a Third and Fourth SARS-CoV-2 Vaccine Dose in Bizen City, Japan
por: Kadowaki, Tomoka, et al.
Publicado: (2023)

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
por: Harberts, Aenne, et al.
Publicado: (2022)

Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients
por: Affeldt, Patrick, et al.
Publicado: (2022)

Quantitative and Qualitative Difference in Antibody Response against Omicron and Ancestral SARS-CoV-2 after Third and Fourth Vaccination
por: Hein, Sascha, et al.
Publicado: (2022)

Fourth-dose boosters with COVID-19 mRNA vaccines well tolerated
Publicado: (2022)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
por: Joo, Yoosun, et al.
Publicado: (2023)

Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
por: Zhang, Ali, et al.
Publicado: (2022)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults
por: Eliakim-Raz, Noa, et al.
Publicado: (2022)

Humoral response after a third and fourth dose of mRNA-based SARS-CoV-2 vaccine in previously seronegative kidney transplant recipients
por: Brandstetter, Clara, et al.
Publicado: (2022)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses
por: Roeder, Alexa J., et al.
Publicado: (2022)

Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine
por: Anichini, Gabriele, et al.
Publicado: (2022)

Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine
por: Matsumoto, Naomi, et al.
Publicado: (2022)

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis
por: John, Binu V., et al.
Publicado: (2022)

Korobov polynomials of the third kind and of the fourth kind
por: Kim, Taekyun, et al.
Publicado: (2015)

Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
por: Ishizaka, Aya, et al.
Publicado: (2023)

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
por: Rescigno, Maria, et al.
Publicado: (2023)

Fourth dose of COVID-19 vaccines in Israel
por: Burki, Talha Khan
Publicado: (2022)

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
por: Bao, Yi, et al.
Publicado: (2020)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma
por: Goldwater, Marissa-Skye, et al.
Publicado: (2023)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
por: Magen, Ori, et al.
Publicado: (2022)

mRNA Vaccines Induce Rapid Antibody Responses in Mice
por: Gebre, Makda S., et al.
Publicado: (2021)

mRNA vaccines induce rapid antibody responses in mice
por: Gebre, Makda S., et al.
Publicado: (2022)

Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people
por: Hagiya, Hideharu, et al.
Publicado: (2022)

HETEROLOGOUS THIRD AND FOURTH DOSE VACCINE TO REDUCE SEVERITY AND MORTALITY IN COVID-19 PATIENTS DURING DELTA AND OMICRON PREDOMINANT IN THAILAND
por: Chariyalertsak, S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_coepmqpm6fpk1od30vuv4higan